Tohoy, Arnel .

HRN: 27-64-98  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2025
CEFTRIAXONE 1G (VIAL)
08/19/2025
08/25/2025
IV
2g
Od
Infected Wound
Checking Initial Appropriateness 
08/19/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/19/2025
08/25/2025
IV
600mg
Q6h
Infected Wound
Checking Initial Appropriateness 
08/21/2025
CEFTAZIDIME 1GM (VIAL)
08/21/2025
08/28/2025
IVTT
1 Gram
Q12
Infected Wound
Checking Initial Appropriateness 
08/23/2025
CEFTAZIDIME 1GM (VIAL)
08/23/2025
08/30/2025
IV
1g
Q8
Cellulitis, Left Foot
Checking Initial Appropriateness 
08/24/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/24/2025
08/31/2025
IV
2.25g
Q6H
Infected Foot L
Checking Initial Appropriateness 
08/29/2025
MUPIROCIN 2%, 15G (TUBE)
08/29/2025
09/04/2025
TOPICAL
2g
Twice A Day
Infected Wound
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: